亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Rising Cases of Drug-Induced Pulmonary Fibrosis: Analysis of the Food and Drug Administration Adverse Event Reporting System (Faers) Database, 2000-2022

不良事件报告系统 食品药品监督管理局 不利影响 药品 医学 数据库 药品管理局 遗产管理(遗嘱认证法) 药理学 计算机科学 政治学 法学
作者
Kenneth L. McCall,Kelsey R. Hennig,Zachary T. Abe,Danielle N. Dattler,Karyssa L. Hurd,Sophie L. Portnoy,Zoey J. Zagoria
出处
期刊:Social Science Research Network [RELX Group (Netherlands)]
标识
DOI:10.2139/ssrn.4543693
摘要

Purpose: Pulmonary fibrosis (PF) is a severe, progressive disease which has been increasing in prevalence. We conducted a systematic search in the FDA Adverse Event Reporting System (FAERS) to determine the drugs most commonly suspected with PF.Methods: In a retrospective review of the FAERS database from 2000-2022, we used the search terms “pulmonary fibrosis” and “idiopathic pulmonary fibrosis” and excluded reports with patients under the age of 18 years, and patients with unknown sex or age. Reports were sorted by generic drug names, and counted and trended over time using regression analysis.Results: From 2000-2022, there were 24,095,935 adverse drug events reported in FAERS, of which 17,520 (0.07%) were reported as PF. Excluding reports containing patients with unknown age (5,255), sex (122), and age below 18 years old (155), our final study cohort consisted of 11,988 reports. The mean age of the study cohort was 66.5 + 13.1 years and 6,248 patients (52.1%) were male. The lowest and highest number of reports per year were 252 and 1,049 reports in 2001 and 2020, respectively, which reflected an increase of 316%. Linear and exponential regression on the entire cohort of 11,988 reports revealed positive slopes over time with an R2 of 0.81 and 0.88, respectively. The top five drug classes associated with PF were disease modifying antirheumatic drugs (DMARDs, 39.4%), antineoplastic agents (26.4%), cardiovascular agents (12.6%), corticosteroids (4.6%), and immunosuppressive agents (4.0%). The top 10 drugs reported to be associated with PF from 2000 to 2022 were methotrexate (1,350, 11.3%), etanercept (977, 8.1%), adalimumab (819, 6.8%), amiodarone (792, 6.6%), infliximab (565, 4.7%), rituximab (561, 4.6%), hydroxychloroquine (515, 4.3%), leflunomide (406, 3.3%), tocilizumab (389, 3.2%), and abatacept (430, 3.5%). Linear regression on the number of reports for each of the top 10 drugs revealed a significant positive slope from 2000 to 2022 for methotrexate, etanercept, adalimumab, rituximab, hydroxychloroquine, leflunomide, tocilizumab, and abatacept (all, p<0.01). Amiodarone and infliximab did not have a slope that differed significantly from a null hypothesis of stable reports over time.Conclusion: A 23-year analysis of the FAERS database revealed exponentially increasing adverse event reports of PF. Significant annual increases in reporting of PF suspected with DMARDs and antineoplastic agents were identified. While our study has limitations, it highlights important trends which should be used to guide PF research related to drugs of potential importance.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
3秒前
小邹发布了新的文献求助10
9秒前
fpy完成签到,获得积分10
11秒前
wx完成签到,获得积分10
11秒前
清爽老九发布了新的文献求助10
16秒前
19秒前
单纯寄云完成签到,获得积分10
20秒前
澹青云完成签到 ,获得积分10
23秒前
清爽老九完成签到,获得积分0
28秒前
Nobodyet完成签到,获得积分10
30秒前
江蹇完成签到,获得积分10
33秒前
深情安青的应助被小邹采纳,获得10
49秒前
1874发布了新的文献求助100
53秒前
受不了12345完成签到,获得积分10
53秒前
57秒前
petrichor发布了新的文献求助10
1分钟前
1分钟前
大猩猩发布了新的文献求助30
1分钟前
之桃完成签到,获得积分10
1分钟前
感性的鸡完成签到,获得积分10
1分钟前
英俊鼠标完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
xxrr发布了新的文献求助30
1分钟前
1分钟前
你奶奶发布了新的文献求助10
2分钟前
小二郎的应助被你奶奶采纳,获得10
2分钟前
2分钟前
从容美女发布了新的文献求助10
2分钟前
2分钟前
2分钟前
阿雷发布了新的文献求助10
2分钟前
ccc发布了新的文献求助10
3分钟前
粗心的烨伟完成签到,获得积分10
3分钟前
3分钟前
3分钟前
情怀的应助被科研通管家采纳,获得30
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190113
求助须知:如何正确求助?哪些是违规求助? 9577216
关于积分的说明 21852162
捐赠科研通 7788317
什么是DOI,文献DOI怎么找? 3436259
关于科研通互助平台的介绍 2559990
邀请新用户注册赠送积分活动 2482862